VECT-HORUS
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB). Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.
VECT-HORUS
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
2005-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.vect-horus.com
Total Employee:
11+
Status:
Active
Contact:
+33(0)4 91 69 87 81
Email Addresses:
[email protected]
Total Funding:
18 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Font API LetsEncrypt SSL By Default Nginx Apache
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
SCR Provençale et Corse
SCR Provençale et Corse investment in Venture Round - VECT-HORUS
Financière Tuileries Co-Invest
Financière Tuileries Co-Invest investment in Venture Round - VECT-HORUS
CAAP Creation
CAAP Creation investment in Venture Round - VECT-HORUS
Incubateur Impulse
Incubateur Impulse investment in Non Equity Assistance - VECT-HORUS
Key Employee Changes
| Date | New article |
|---|---|
| 2023-04-03 | Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer |
Official Site Inspections
http://www.vect-horus.com Semrush global rank: 8.9 M Semrush visits lastest month: 455
- Host name: sweb.contingences.com
- IP address: 51.15.162.93
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "VECT-HORUS"
VECT-HORUS - Crunchbase Company Profile & Funding
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and …See details»
Vect-Horus 2025 Company Profile: Valuation, Funding …
Vect-Horus was founded in 2005. Where is Vect-Horus headquartered? Vect-Horus is headquartered in Marseille, France. What is the size of Vect-Horus? …See details»
Vect-Horus SAS - Drug pipelines, Patents, Clinical trials - Synapse
About Vect-Horus Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumors. Founded in 2005, …See details»
VECT-HORUS - Funding, Financials, Valuation & Investors
VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain. ... Solutions. Products. Resources. Pricing. …See details»
Vect-Horus
Vect-Horus is co-developing with Radiomedix one agent which will enter clinical trials in 2021 for the diagnosis of glioblastoma. With Cerimed, Vect-Horus also pursues the investigations on its …See details»
VECT-HORUS Company Profile - Office Locations, Competitors
VECT-HORUS is a biotech company that develops peptide-based vectors to facilitate the delivery of drugs or imaging agents into the brain and to tumors. It focuses on targeted delivery by …See details»
Société VECT-HORUS : Chiffre d'affaires, statuts, extrait d ... - Pappers
Mar 13, 2025 VECT-HORUS à MARSEILLE (13005) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS, SIREN, …See details»
VECT-HORUS - Contacts, Employees, Board Members, Advisors
Organization. VECT-HORUS . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Vect-Horus appoints Carole Imbert as Chief Financial
2 days ago Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain, and to tumors. Founded in 2005, …See details»
A pioneer in drug delivery with an innovative targeting …
VECT-HORUS currently has 35 employees, most of whom are scientists. Since its inception, VECT-HORUS has raised about €30 million of which €20 million from private investors and €10 million through different types of public funds. …See details»
Vect-Horus - Viva Technology
Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain, and to tumors. Founded in 2005, Vect-Horus is …See details»
Vect-Horus
Meet Vect-Horus at the 3rd Annual Next Gen Lipid-Based Nanoparticles Delivery Summit, Boston, August 21-23, 2024. 2024/08/20. Poster presentation at the Association for Research in Vision …See details»
Vect-Horus - Raised $23.2M Funding from 3 investors - Tracxn
Feb 26, 2025 Vect-Horus has raised a total funding of $23.2M over 9 rounds from 3 investors. Investors include European Union, Advanced Accelerator Applications and 1 other. Their latest …See details»
VECT-HORUS - Biotech.info
VECT-HORUS, en collaboration avec l’équipe BHE et Neuroinflammation de l’INP a développé la plateforme technologique VECTrans®, unique en Europe, pour le développement de vecteurs …See details»
Vect-Horus appoints Carole Imbert as Chief Financial Officer to …
2 days ago Marseille, France, March 25, 2025 - Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of …See details»
Vect-Horus poursuit le renforcement son équipe de direction
2 days ago Vect-Horus conçoit et développe des molécules « vecteurs » qui facilitent l’adressage de molécules thérapeutiques ou d’agents d’imagerie vers des organes cibles, …See details»
Vect-Horus SAS (Vect-Horus SAS) - 药物管线_专利_临床试验_投融 …
About Vect-Horus Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumors. Founded in 2005, …See details»
Vect-Horus further strengthens leadership with appointment
Jan 28, 2025 Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain, and to tumors. Founded in 2005, …See details»
Customized vectors for targeted drug delivery - Nature
Vect-Horus’ unique technology platform, VECTrans, is dedicated to the discovery and optimization of innovative drug delivery vectors and is available for pharmaceutical and biotechcompanies …See details»
How blood–brain barrier technology is unleashing CNS therapies
With its innovative VECTrans platform, Vect-Horus is enabling targeted drug delivery across the blood–brain barrier, potentially transforming the treatment of neurodegenerative disorders.See details»